Literature DB >> 19109897

Capture of authentic embryonic stem cells from rat blastocysts.

Mia Buehr1, Stephen Meek, Kate Blair, Jian Yang, Janice Ure, Jose Silva, Renee McLay, John Hall, Qi-Long Ying, Austin Smith.   

Abstract

Embryonic stem (ES) cells have been available from inbred mice since 1981 but have not been validated for other rodents. Failure to establish ES cells from a range of mammals challenges the identity of cultivated stem cells and our understanding of the pluripotent state. Here we investigated derivation of ES cells from the rat. We applied molecularly defined conditions designed to shield the ground state of authentic pluripotency from inductive differentiation stimuli. Undifferentiated cell lines developed that exhibited diagnostic features of ES cells including colonization of multiple tissues in viable chimeras. Definitive ES cell status was established by transmission of the cell line genome to offspring. Derivation of germline-competent ES cells from the rat paves the way to targeted genetic manipulation in this valuable biomedical model species. Rat ES cells will also provide a refined test-bed for functional evaluation of pluripotent stem cell-derived tissue repair and regeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109897     DOI: 10.1016/j.cell.2008.12.007

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  299 in total

1.  Generating gene knockout rats by homologous recombination in embryonic stem cells.

Authors:  Chang Tong; Guanyi Huang; Charles Ashton; Ping Li; Qi-Long Ying
Journal:  Nat Protoc       Date:  2011-05-26       Impact factor: 13.491

Review 2.  Stem cell-derived vascular endothelial cells and their potential application in regenerative medicine.

Authors:  Hera Chaudhury; Eric Raborn; Lauren C Goldie; Karen K Hirschi
Journal:  Cells Tissues Organs       Date:  2011-10-14       Impact factor: 2.481

3.  Sleeping Beauty transposon mutagenesis in rat spermatogonial stem cells.

Authors:  Zoltán Ivics; Zsuzsanna Izsvák; Gerardo Medrano; Karen M Chapman; F Kent Hamra
Journal:  Nat Protoc       Date:  2011-09-08       Impact factor: 13.491

4.  Gene targeting: Enter the rat.

Authors:  F Kent Hamra
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

Review 5.  Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues.

Authors:  Jacob H Hanna; Krishanu Saha; Rudolf Jaenisch
Journal:  Cell       Date:  2010-11-12       Impact factor: 41.582

6.  Recombinant rabbit leukemia inhibitory factor and rabbit embryonic fibroblasts support the derivation and maintenance of rabbit embryonic stem cells.

Authors:  Fei Xue; Yinghong Ma; Y Eugene Chen; Jifeng Zhang; Tzu-An Lin; Chien-Hong Chen; Wei-Wen Lin; Marsha Roach; Jyh-Cherng Ju; Lan Yang; Fuliang Du; Jie Xu
Journal:  Cell Reprogram       Date:  2012-07-09       Impact factor: 1.987

7.  Development of a BAC vector for integration-independent and tight regulation of transgenes in rodents via the Tet system.

Authors:  Kai Schönig; David Kentner; Manfred Gossen; Tina Baldinger; Jun Miao; Katrin Welzel; Andreas Vente; Dusan Bartsch; Hermann Bujard
Journal:  Transgenic Res       Date:  2010-07-18       Impact factor: 2.788

Review 8.  Interspecies chimeric complementation for the generation of functional human tissues and organs in large animal hosts.

Authors:  Jun Wu; Juan Carlos Izpisua Belmonte
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

9.  Rapid conversion of human ESCs into mouse ESC-like pluripotent state by optimizing culture conditions.

Authors:  Qi Gu; Jie Hao; Xiao-yang Zhao; Wei Li; Lei Liu; Liu Wang; Zhong-hua Liu; Qi Zhou
Journal:  Protein Cell       Date:  2012-01-21       Impact factor: 14.870

10.  Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality.

Authors:  Ludovic Zimmerlin; Tea Soon Park; Jeffrey S Huo; Karan Verma; Sarshan R Pather; C Conover Talbot; Jasmin Agarwal; Diana Steppan; Yang W Zhang; Michael Considine; Hong Guo; Xiufeng Zhong; Christian Gutierrez; Leslie Cope; M Valeria Canto-Soler; Alan D Friedman; Stephen B Baylin; Elias T Zambidis
Journal:  Development       Date:  2016-09-22       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.